Document:

<PAGE>   1

                                                                    EXHIBIT 10.4
                              ROYAL CROWN COLA CO.
                              1000 CORPORATE DRIVE
                            FT. LAUDERDALE, FL 33334

                                January 28, 1994

Mr. Fraser Latta
Vice Chairman & Chief Operating Officer
Cott Corporation
6526 Viscount Road
Mississauga, Ontario

Mr. Ed Szczepanowski
Vice President
BCB International Limited
Chancery House
High Street
Bridgetown, Barbados
West Indies

     RE: RCC/Cott Supply Agreement

     Gentlemen:

     Reference is made to the Concentrate Sales Agreement between Royal Crown
Cola Co. ('RCC') and Cott Corporation ('Cott') which commenced June 1, 1991 (the
'Supply Agreement'). This letter outlines the terms and conditions upon which
(i) RCC will assign its rights under the Supply Agreement to BCB International
Limited ('BCB'), a wholly owned subsidiary of Cott, and (ii) RCC will enter into
a new concentrate supply agreement (the 'New Supply Agreement') with BCB. Cott
and all of its present and future subsidiaries and affiliates are hereinafter
collectively referred to as the 'Cott Group.'

     1. ASSIGNMENT OF EXISTING RCC RIGHTS. RCC will assign to BCB all of RCC's
rights and obligations under the Supply Agreement, in exchange for BCB agreeing
to enter into this New Supply Agreement and for the payment to RCC of $ *
[CONFIDENTIAL TREATMENT HAS BEEN REQUESTED] upon execution of the New Supply
Agreement. This assignment is to be effective as of the effective date of the
New Supply Agreement and Cott hereby consents to this assignment.

     2. PRODUCTS AND SCOPE. RCC will manufacture and sell to BCB, and BCB will
purchase, from RCC, all of the Cott Group's worldwide requirements for cola
concentrates, or cola emulsions used in the production of concentrates, which
concentrates and emulsions are used in the production of private label and Cott
Group proprietary label carbonated soft drinks ('CSDs'), which CSDs will be sold
to consumers in bottles, cans or other containers (collectively 'PL Cola
Concentrates') and will be produced, bottled or sold by or on behalf of the Cott
Group. Wherever possible, BCB will use commercially reasonable efforts to
purchase all of the Cott Group's worldwide requirements for non-cola
concentrates, or non-cola emulsions used in the production of concentrates,
which concentrates and emulsions are used in the production of private label and
Cott Group proprietary label CSDs, which CSDs will be sold to consumers in
bottles, cans or other containers (collectively 'PL Non-Cola Concentrates' and,
together with PL Cola Concentrates, 'PL Concentrates') and will be produced,
bottled or sold by or on behalf of the Cott Group. BCB agrees that during
calendar 1995 and each year thereafter, at least 75% of the Cott Group's

<PAGE>   2

aggregate worldwide requirements for PL Concentrates will be purchased from RCC.
On or prior to March 31, 1996 and on or prior to March 31 of each year
thereafter, the Cott Group will deliver a statement based on internal case sales
data of the Cott Group, certified as having been derived from such internal
sales data by the independent auditors of the Cott Group, as to whether such 75%
requirement was met during the immediately preceding year. RCC may, at its
request and at its costs, conduct an audit of such case sales data. If the Cott
Group fails to satisfy the foregoing 75% requirement in any year, RCC will be
permitted to sell PL Concentrates to other customers, but BCB will continue to
be obligated to buy all of the Cott Group's requirements for PL Cola
Concentrates exclusively from RCC and to use commercially reasonable efforts to
purchase, wherever possible, all of the Cott Group's requirements for PL
Non-Cola Concentrates exclusively from RCC. Subject to paragraph 6 hereof, in
the event that the Cott Group purchases any PL Cola Concentrates from anyone
other than RCC and the Cott Group fails to cure such breach within 15 days after
notice from RCC, RCC, in addition to all of its other rights and remedies under
the New Supply Agreement and applicable law, shall have the right to terminate
the New Supply Agreement upon thirty (30) days written notice and to pursue all
of its rights and remedies under applicable law against the Cott Group for
breach of contract.

     3. USE OF NAME. The Cott Group may advise its customers and other
interested parties that its PL Concentrates are made by RCC. However, the Cott
Group may not state or imply that any particular formula is RC Cola, Diet-Rite,
or any other branded product of RCC. The Cott Group shall not, and the Cott
Group shall cause its customers not to, use any of RCC's trademarks or RCC's
name in any way in connection with the production, labeling, advertising,
display or marketing of the private label and proprietary label CSDs produced or
sold by or on behalf of the Cott Group.

     4. OWNERSHIP OF FORMULAE. RCC will be the developer, formulator and
supplier of all PL Concentrates for CSDs which will be produced, bottled or sold
by or on behalf of the Cott Group and which are subject to the terms of the New
Supply Agreement. All rights and title to all formulae developed after the date
of the New Supply Agreement, whether developed by RCC, the Cott Group or jointly
by RCC and the Cott Group, shall belong exclusively to RCC. Formulae designed by
the Cott Group prior to the effective date of the New Supply Agreement shall
continue to belong to the Cott Group. Formulae designed by RCC prior to the
effective date of the New Supply Agreement shall continue to belong to RCC.
Formulae designed by RCC and Cott jointly prior to the effective date of the New
Supply Agreement shall continue to be jointly owned. Exhibits B and C hereto
identify the '800' and '900' Series products, the formulae for which are owned
by the Cott Group, and the '200,' '300,' '400,' and '500' Series products, the
formulae for which are owned by RCC. During the term of the New Supply Agreement
and any renewals thereof RCC agrees not to utilize any of the formulae supplied
to BCB for any other purpose without the written consent of BCB. Upon
termination of the New Supply Agreement because one party has elected not to
renew under Paragraph 10 hereof, formulae developed by the non-electing party,
formulae developed by the electing party which are in use at the time and
formulae developed by both parties jointly shall belong to the non-electing
party. Upon termination of the New Supply Agreement as a result of a breach or
failure to perform by one party, formulae developed by the non-breaching party,
formulae developed by the breaching party which are in use at the time and
formulae developed by both parties jointly shall belong to the non-breaching
party.

     5. PERFORMANCE MINIMUMS. Except as provided in the immediately succeeding

                                                                               2

<PAGE>   3

sentence, RCC will agree not to sell PL Concentrates to anyone in the world
other than BCB. In the event that BCB fails in any calendar year to purchase PL
Concentrates from RCC which equal or exceed 100 million 12 ounce case
equivalents ('Cases') RCC may by written notice to BCB by April 30 of the
following year elect to sell PL Cola Concentrates and/or PL Non-Cola
Concentrates to other customers. If the volume purchased by BCB from RCC during
any calendar year declines by 20% or more in comparison to the immediately
preceding year for two consecutive years, RCC may by written notice to BCB by
April 30 of the year immediately following the second year in which BCB failed
to purchase the minimum volumes required, elect to sell PL Cola Concentrates
and/or PL Non-Cola Concentrates to other customers. If RCC elects to sell PL
Cola Concentrates to other customers, BCB may, by written notice to RCC within
90 days after receipt of RCC's election, elect to purchase PL Cola Concentrates
from suppliers other than RCC, in which case RCC shall continue to be obligated
to supply PL Cola Concentrates to BCB under the terms and conditions of the New
Supply Agreement. If RCC elects to sell PL Non-Cola Concentrates to other
customers, BCB may, by written notice to RCC within 90 days after receipt of
RCC's election, elect to purchase PL Non-Cola Concentrates from suppliers other
than RCC, in which case RCC shall continue to be obligated to supply PL Non-Cola
Concentrates to BCB under the terms and conditions of the New Supply Agreement.

6.   ACQUISITIONS.

     6.1 In the event that the Cott Group acquires a business, whether through
an acquisition of stock or assets or some other form of transaction, that
purchases concentrates from a source other than RCC as a result of contractual
obligations and/or commercial relationships not evidenced by contractual
obligations, then notwithstanding the provisions of paragraph 2, (i) the
acquired business shall be permitted to continue to purchase concentrates from
the same non-RCC sources to the extent that it is contractually obligated to do
so or for a period of twelve (12) months after the date of acquisition of such
business by the Cott Group and (ii) in the case of a commercial relationship not
evidenced by a contractual obligation, the acquired business shall be permitted
to continue to purchase concentrates a from the same non-RCC source for a period
not exceeding twelve (12) months after the date of acquisition of such business
by the Cott Group. Concentrates purchased by the acquired business from non-RCC
sources pursuant to the preceding sentence shall not be included in the
calculations of the 75% test under Paragraph 2 for a period of twelve (12)
months after the date of acquisition of such business by the Cott Group.

     6.2 Anything in paragraph 6.1 notwithstanding, (a), wherever possible, the
Cott Group shall use commercially reasonable efforts to cause the acquired
business to cease purchasing cola and non-cola concentrates from sources other
than RCC as soon as possible, (b) the acquired business shall not be permitted
to sell cola concentrates manufactured by sources other than RCC or CSDs made
from cola concentrates manufactured by sources other than RCC to any customers
other than the customers it served at the time of its acquisition by the Cott
Group, (c) the Cott Group shall use commercially reasonable efforts to cause the
acquired business to cease selling non-cola concentrates manufactured by sources
other than RCC or CSDs made from non-cola concentrates manufactured by sources
other than RCC to any customers other than the customers it served at the time
of its acquisition by the Cott Group and (d) the Cott Group shall not renew or
extend or permit the renewal or extension of any contractual obligation of an
acquired business to purchase cola concentrates from a source other than RCC.

     6.3 RCC will work with BCB to supply to the acquired business concentrates
or emulsions of a quality and taste similar to those which the acquired business

                                                                               3
<PAGE>   4

purchased from sources other than RCC (hereinafter 'Replacement Concentrates').
The prices for Replacement Concentrates will be equal to the cost of
ingredients, packaging and freight of $ * [CONFIDENTIAL TREATMENT HAS BEEN
REQUESTED] per Case plus $ * [CONFIDENTIAL TREATMENT HAS BEEN REQUESTED] per
Case. On the third anniversary of the effective date of the New Supply Agreement
and on every third anniversary thereafter, the $ * [CONFIDENTIAL TREATMENT HAS
BEEN REQUESTED] per Case rate shall be adjusted proportionately in accordance
with the adjustments to the prices set forth in Exhibit A. Thus, if the prices
in Exhibit A are increased 10%, then the $ * [CONFIDENTIAL TREATMENT HAS BEEN
REQUESTED] per Case rate for Replacement Concentrates shall increase to $ *
[CONFIDENTIAL TREATMENT HAS BEEN REQUESTED]. Replacement Concentrates shall be
omitted from the calculations of the 75% test under Paragraph 2.

     6.4 Except as provided by the terms of the New Supply Agreement, in no
event will the Cott Group engage in the business of manufacturing or selling
concentrates or branded CSDs without RCC's prior written consent. For purposes
of this paragraph, branded CSDs refers to CSDs which are marketed, distributed
and priced in substantially the same manner as the products produced by the two
major cola companies. In the event that the Cott Group wishes to acquire a
company or business that is engaged in the business of manufacturing or selling
concentrates or branded CSDs in competition with RCC (a 'Cott Restricted
Business'), then the Cott Group shall discontinue the Cott Restricted Business
or sell the Cott Restricted Business to a third party not affiliated with the
Cott Group within 12 months after the Cott Group acquires the Cott Restricted
Business. RCC shall have a right of first refusal to purchase the Cott
Restricted Business.

     6.5 In the event that RCC acquires a company or business that sells PL
Concentrates to customers other than the Cott Group, then notwithstanding the
provisions of paragraph 5, (i) the acquired entity shall be permitted to
continue to sell PL Concentrates to customers other than the Cott Group to the
extent that it is contractually obligated to do so and (ii) in the case of
commercial relationships not evidenced by a contractual obligation, the acquired
entity shall be permitted to sell PL Concentrates to customers other than the
Cott Group for a period not exceeding twelve (12) months from the date of the
acquisition of such entity by RCC. Notwithstanding the foregoing, (a) wherever
possible RCC will use commercially reasonable efforts to cause the acquired
entity to cease selling PL Concentrates to customers other than the Cott Group
as soon as possible (b) the acquired entity shall not be permitted to sell PL
Concentrates to any customers other than the customers it served at the time of
its acquisition by RCC (c) RCC shall not extend or permit the renewal of any
contractual obligation pursuant to which the acquired entity sells PL
Concentrates to customers other than the Cott Group, and (d) RCC will not
undertake any improvement or changes to the PL Concentrates being manufactured
by the acquired entity for sale to customers other than the Cott Group. For
greater certainty, RCC will not supply its concentrates or emulsions to the
acquired entity except for sale to the Cott Group.

     6.6 The Cott Group will, wherever possible, use commercially reasonable
efforts to purchase PL Concentrates from the acquired entity in a quantity such
that the acquired entity's sales do not decline as a result of curtailing its
sales of PL Concentrates to customers other than the Cott Group. This paragraph
will not obligate the Cott Group to increase the minimum purchase requirements
contained in paragraph 5 hereof.

                                                                               4

<PAGE>   5

     6.7 In no event will RCC engage in the business of marketing private label
CSDs to retailers without the Cott Group's prior written consent. In the event
that RCC wishes to acquire a company or business that is engaged in the business
of marketing private label CSDs to retailers (an 'RCC Restricted Business'),
then RCC shall discontinue the RCC Restricted Business or sell the RCC
Restricted Business to a third party not affiliated with RCC within 12 months
after RCC acquires the RCC Restricted Business. The Cott Group shall have a
right of first refusal to purchase the RCC Restricted Business.

     7. FIGHTER BRANDS. RCC agrees to work with BCB to supply PL Concentrates to
BCB to meet the demands of BCB's customers for 'fighter brands.' The prices for
such fighter brands shall be negotiated in good faith. RCC agrees that it will
not develop a new brand with a full line of low-priced flavors which is
specifically designed for the warehouse retail distribution system.

     8. RCC PERFORMANCE OBLIGATIONS.

     (a) The PL Concentrates sold by RCC shall comply in all material respects
with all applicable laws, rules and regulations, including the Federal Food,
Drug and Cosmetic Act, at the time of shipment. All PL Concentrates sold by RCC
shall be merchantable and fit for the intended purpose at the time of shipment
and shall be designed to meet the specifications of the customers of the Cott
Group. In the event that RCC's quality control personnel and BCB's
representatives agree that any PL Concentrates sold by RCC do not meet the
foregoing standards, RCC's liability shall be limited to the replacement of the
PL Concentrates and the finished goods made from such defective PL Concentrates
and the reimbursement of costs throughout the supply chain caused by a recall of
products made from such defective PL Concentrates in a fashion consistent with
the policy followed by RCC with respect to a recall of product made from
defective branded concentrate. RCC shall also be responsible for claims by third
parties resulting solely from PL Concentrates proven to be defective. RCC shall
not be responsible for defective PL Concentrates produced by the Barbados
Facility unless RCC's quality control personnel and BCB's representatives
mutually determine in good faith that the emulsions from which such PL
Concentrates were produced were defective.

     (b) BCB agrees to furnish RCC with its projected requirements for PL
Concentrates for each calendar year by not later than December 1 of the
preceding calendar year. BCB shall deliver updated projections of its
requirements for PL Concentrates for the next 12 months on or before March 1,
June 1, and September 1 of each year. All such projections shall specify, on a
month by month basis, BCB's requirements for each flavor or product. BCB shall
also (a) deliver monthly reports to RCC on BCB's actual sales for the preceding
month and (b) notify RCC as soon as possible of any significant business
developments which would be likely to cause changes in its projected
requirements. RCC will agree to deliver PL Concentrates as ordered by BCB,
provided that the volumes actually ordered by BCB do not exceed the amounts
specified in BCB's most recent projections, and RCC will use commercially
reasonable efforts to fill orders by BCB for amounts in excess of such
projections. RCC shall accord the same priority to BCB's orders that it accords
to the orders of RCC's franchises for RCC's branded concentrates. In the event
that RCC repeatedly fails to deliver the volumes ordered by BCB in timely
fashion, provided that such volumes do not exceed the amounts specified in BCB's
most recent projections, and such repeated failures are reasonably determined by
the Cott Group to have had, or may reasonably be expected to have in the future
a material adverse effect on the Cott Group's financial condition or results of
operations, then BCB may notify RCC in writing of such failures.

                                                                               5
<PAGE>   6

RCC shall have the right to demonstrate that the Cott Group's expectations of a
future material adverse effect are unreasonable. If, during the first 365 days
after RCC receives such written notice, deliveries by RCC continue to be
untimely or in amounts substantially less than the amounts ordered by BCB,
provided that the volumes ordered by BCB do not exceed the amounts specified in
BCB's most recent projections, and the Cott Group reasonably determines that
such failures by RCC continue to have had, or may reasonably be expected to have
in the future, a material adverse effect on the Cott Group's financial condition
or results of operation, then the Cott Group may, by written notice, elect to
terminate the New Supply Agreement without prejudice to the Cott Group's other
legal rights and remedies arising out of such breach. RCC shall not be
responsible for failing to fill orders (i) for amounts in excess of the amounts
specified in the projections or (ii) to the extent that such failure resulted
from RCC's inability to obtain raw materials because BCB did not give RCC
sufficient advance notice of a change in BCB's requirements.

     9. PRICING AND PAYMENT. The price structure shall be as set forth in
Exhibit A. BCB shall make all payments to RCC within 30 days of shipment from
RCC's production center.

     10. TERM. The effective date of the New Supply Agreement shall be January
1, 1994 and the initial term of the New Supply Agreement shall be twenty-one
years. The parties agree to negotiate in good faith the terms of an extension to
the New Supply Agreement during the nineteenth year of the effective date of the
New Supply Agreement. If the parties have not agreed to the terms of an
extension by the twentieth anniversary of the effective date of the New Supply
Agreement, then the term of the New Supply Agreement shall be extended for six
years, and the terms and conditions of the extended agreement shall be the same
as the terms and conditions of the New Supply Agreement. The New Supply
Agreement will be subject to similar six-year extensions as follows: at the end
of the fifth year of each extended term, the parties agree to negotiate in good
faith the terms of another extension to the New Supply Agreement. If the parties
have not agreed to the terms of an extension within six months after the fifth
anniversary of the current extension, then the New Supply Agreement will
automatically be extended for an additional six years on the same terms and
conditions. Such six-year extensions shall continue successively notwithstanding
the failure of the parties during any such extension to agree upon the terms and
conditions of another extension. Notwithstanding the foregoing, either party
may, at its election, refuse to agree to any extension of the New Supply
Agreement, in which case Paragraph 4 hereof shall apply to determine ownership
of formulae.

     11. HIRING. The Cott Group and RCC agree not to solicit for hire key
employees from each other's organizations.

     12. NEW INTERNATIONAL ACTIVITIES. RCC acknowledges that it presently
supplies the Cott Group with PL Concentrates in Canada and the United States.
RCC further acknowledges that Cott, through BCB, is actively pursuing the sale
of private label beverages in countries outside of Canada and the United States.
In order to enhance this activity, and to satisfy its obligation under paragraph
one (1) of this letter BCB is contemplating the use of an emulsifying finishing
facility (the 'International Facility') in a location outside the United States
or Canada. BCB expects to acquire or construct the International Facility or to
obtain the use of the International Facility through a lease, license, tolling
or other arrangement through a third party. RCC will cooperate with BCB with
respect to the International Facility, on the understanding that RCC, on behalf

                                                                               6
<PAGE>   7

of BCB, controls and directs 100% of the supply of all concentrate emulsions
manufactured by RCC and sent to the International Facility. The prices for the
emulsions sold by RCC to BCB shall result in the operating profit per Case,
determined in accordance with generally accepted accounting principles, earned
by RCC being equal to the operating profit per Case earned by RCC on PL
Concentrates manufactured at RCC's Columbus, Georgia facility as of December 31,
1993. The Cott Group will indemnify RCC against any duties, fees or taxes
(including withholding, gross receipts, value added, income or other type of
taxes) imposed by the government of the country in which the International
Facility is located that are attributable to the activities contemplated by the
New Supply Agreement. RCC will not bear any development and construction costs
relating to the International Facility. BCB agrees to retain the services of an
employee or employees of RCC or its subsidiaries to occupy the positions of
plant manager and other key positions (as required) of the International
Facility.

     13. QUALITY CONTROL SERVICES. RCC will provide quality control services at
the same level as provided with respect to RCC's own branded products, including
the provision of technical support to the Cott Group's bottling and canning
locations, including the International Facility, provided, however, that RCC
will not be responsible for the selection, testing or approval of container
closures and other packaging materials for the finished CSDs. In consideration
of such services, during each year of the first ten years of the operation of
the International Facility, BCB will pay to RCC a fee of $ * [CONFIDENTIAL
TREATMENT HAS BEEN REQUESTED]. Such fee will be payable upon the commencement of
operations of the International Facility and on each of the first *
[CONFIDENTIAL TREATMENT HAS BEEN REQUESTED] anniversaries thereof.

     14. GUARANTY. Cott will guarantee all of BCB's obligations under the New
Supply Agreement.

     15. USE OF RCC BOTTLERS. Cott agrees to use commercially reasonable efforts
to cause the private label and proprietary label CSDs produced in North America
in bottles, cans or other containers by the Cott Group to be bottled by RCC's
franchisees wherever possible, provided, however, that the Cott Group shall be
relieved of such obligation to the extent that a franchisee does not have the
physical or technical capability to meet Cott's requirements on the most
cost-effective basis, as determined by Cott in its sole discretion.

     16. FOUNTAIN SYRUP. During the period January 1, 1994 through December 31,
1995, RCC will manufacture and sell to BCB, and BCB will purchase, all of the
Cott Group's worldwide requirements for cola concentrates or cola emulsions used
in the production of cola concentrates used in the production of private label
and Cott Group proprietary label fountain syrup (collectively 'PL Cola Fountain
Syrup') produced or sold by or on behalf of the Cott Group. Wherever possible,
BCB will during such two-year period use commercially reasonable efforts to
purchase all of the Cott Group's worldwide requirements for non-cola
concentrates or non-cola emulsions used in the production of concentrate used in
the production of private label and Cott Group proprietary label fountain syrup
(collectively 'PL Non-Cola Fountain Syrup' and, together with PL Cola Fountain
Syrup, 'PL Fountain Syrup') produced or sold by or on behalf of the Cott Group.
BCB agrees that during 1995, at least 75% of the Cott Group's aggregate
worldwide requirements for PL Fountain Syrup will be purchased from RCC. During
this two-year period, RCC will not sell PL Fountain Syrup to customers other
than the Cott Group. The pricing for the PL Fountain Syrup will be $ *
[CONFIDENTIAL TREATMENT HAS BEEN REQUESTED] per Case for regular

                                                                               7
<PAGE>   8

colas and diet colas, with diet colas adjusted for any differences in costs of
ingredients and direct packaging. Such costs and prices will be reviewed
quarterly and adjusted by the same mechanisms as are set forth in Exhibit A.
Additionally, RCC will provide PL Fountain Syrup packing to Cott at a rate
competitive with the rate charged by other national fountain syrup packers.

     If Cott commits to developing the sales in the fountain syrup segment
during this two-year period, then Cott and RCC will negotiate appropriate
performance minimums for PL Fountain Syrup and PL Fountain Syrup will be made
subject to the New Supply Agreement. If the parties are unable to agree on
appropriate performance minimums for PL Fountain Syrup, then PL Fountain Syrup
will not be subject to the New Supply Agreement and the parties will have no
obligations to each other with respect to PL Fountain Syrup. If the Cott Group
decides during the two-year period not to pursue the development of sales in the
PL Fountain Syrup segment, then BCB will so advise RCC on behalf of itself and
the Cott Group. RCC will be free to sell PL Fountain Syrup to other customers if
the Cott Group decides not to pursue sales in the fountain syrup segment.

     17. MISCELLANEOUS. All references herein to '$' or 'dollars' are references
to United States dollars. All references herein to the Cott Group shall be
deemed to be references to each member of the Cott Group and to all members of
the Cott Group collectively. RCC shall have the right to utilize the foreign
sales corporation provisions of the Internal Revenue Code and to assign its
rights and obligations under the New Supply Agreement, provided that RCC fully
guarantees the assignee's obligations thereunder.

     The foregoing is a binding contractual obligation of each of RCC and
Cottand BCB. The parties intent to execute and deliver a definitive New Supply
Agreement, but until a definitive New Supply Agreement is executed, this letter
agreement shall be deemed a binding agreement.

                                       Very truly yours,

                                       ROYAL CROWN COLA CO.

                                       By: /s/ John C. Carson
                                          -------------------------------------
                                           John C. Carson, President

Accepted and agreed:
COTT CORPORATION

BY: /s/ Fraser Latta
   -----------------------------
    Fraser Latta
    Vice Chairman & COO

BCB INTERNATIONAL LIMITED

BY: /s/ Ed Szczepanowski
   -----------------------------
    Ed Szczepanowski
    Vice President

                     RCC/COTT SUPPLY AGREEMENT -- EXHIBIT A

                                                                               8
<PAGE>   9

                   [CONFIDENTIAL TREATMENT HAS BEEN REQUESTED]

                     RCC/COTT SUPPLY AGREEMENT -- SCHEDULE B

                   [CONFIDENTIAL TREATMENT HAS BEEN REQUESTED]

                     RCC/COTT SUPPLY AGREEMENT -- SCHEDULE C

                   [CONFIDENTIAL TREATMENT HAS BEEN REQUESTED]<PAGE>   1

                                                                    EXHIBIT 10.5

                              EMPLOYMENT AGREEMENT

THIS AGREEMENT made this 11th day of June, 1998.

B E T W E E N:

COTT CORPORATION,
a corporation incorporated under the laws of Canada

(hereinafter referred to as the "Corporation")

OF THE FIRST PART

 - and -

FRANK E. WEISE III,
of the Town of Haverford, in the State of Pennsylvania

 (hereinafter referred to as the "Executive")

OF THE SECOND PART

     WHEREAS the Corporation and the Executive have agreed to enter into this
Employment Agreement to formalize in writing the terms and conditions reached
between them governing the Executive's employment;

     NOW THEREFORE in consideration of the covenants and agreements herein
contained and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged by the parties, the parties hereto
agree as follows:

ARTICLE 1 - COMMENCEMENT AND TERM

1.1 TERM. Subject to earlier termination in accordance with Article 5 hereof,
the term of this Agreement shall commence on June 1, 1998 and shall continue for
a maximum term ending on January 31, 2002 (the "Term"). The Term shall renew
automatically for consecutive periods of one (1) year each, unless one party
gives notice to the other that it does not wish to renew the then current Term
(a "Notice of Non-Renewal"). To be effective, such Notice of Non-Renewal must be
received by the receiving party not later than one hundred and eighty (180) days
prior to the end of the relevant Term. In the event that a Notice of Non-Renewal
is delivered, this Agreement and the employment of the Executive shall
automatically end at the expiry of the then relevant Term without further
obligation by the Corporation (except for the provisions of Articles 4 and 5
which shall continue in accordance with their terms).

<PAGE>   2

ARTICLE 2 - EMPLOYMENT

2.1 POSITION. Subject to the terms and conditions hereof, the Executive shall be
employed by the Corporation in the office of President and Chief Executive
Officer of the Corporation and shall perform such duties and exercise such
powers and responsibilities of such office as are set forth in the Statement of
Responsibilities - Chief Executive Officer attached hereto which has been
approved by the board of directors, as are contained in the by-laws of the
Corporation and as are otherwise prescribed or specified from time to time by
the board of directors of the Corporation. The Executive shall also be appointed
as a director of the Corporation as soon as practicable following execution
hereof.

2.2 RESPONSIBILITIES. The Executive agrees to devote substantially all of his
business time and attention to the business and affairs of the Corporation, to
discharge the responsibilities assigned to the Executive, and to use the
Executive's best efforts to perform faithfully and efficiently such
responsibilities. Other than for the Corporation and any of its subsidiary or
related entities, or for directorships held by the Executive at the time of
execution of this Agreement, the Executive shall not serve as a director or in a
similar function with any other entities for the first 18 months of the Term
but, thereafter, the Executive shall be entitled to serve as a director on
external boards of directors, subject to the prior written approval of the
Corporation. Anything herein to the contrary notwithstanding, nothing shall
preclude the Executive from (i) serving on the boards of directors of a
reasonable number of trade associations and/or charitable organizations, (ii)
engaging in charitable activities and community affairs, and (iii) managing his
personal investments and affairs, provided that any or all of the foregoing
activities do not materially interfere with the proper performance of his duties
and responsibilities as the Corporation's President and Chief Executive Officer.

ARTICLE 3 - REMUNERATION

3.1 SALARY. During the Term, the Corporation shall pay the Executive a base
salary (the "Base Salary") to be fixed by the board of directors of the
Corporation from time to time, payable monthly in arrears. The Base Salary shall
be not less than $425,000 per annum and shall be reviewed no less frequently
than annually for increase in the discretion of the board of directors, it being
understood that there is no mutual expectation of the parties that Base Salary
will be increased during the period ending January 31, 2002.

3.2 BONUSES. The Executive shall be entitled to an annual performance-based
bonus (the "Bonus") with a target of one hundred percent (100%) of his Base
Salary as determined by the board of directors or a committee thereof, such
Bonus to be based on the achievement of specific objectives to be established
and mutually agreed upon on an annual basis. For the fiscal year ending January
31, 1999, the Corporation shall pay the Executive a bonus in the amount of
$175,000. Bonuses shall be earned and payable only upon completion of the
relevant fiscal year and provided the Executive shall continue to be actively
and continuously employed for the full duration thereof, unless otherwise
provided in Article 5.

<PAGE>   3

3.3      BENEFITS AND PERQUISITES.

         (a) The Executive shall be entitled to participate in all of the
Corporation's group insurance benefit plans, currently including basic medical,
extended health, dental, long term disability, travel and accident insurance.
All plans are governed by their terms.

         (b) The Corporation shall provide the Executive with supplemental
disability benefits which would pay the Executive, in the event of his
termination for Disability (as defined in Section 5.1(c)), an amount equal to
the sum of 60% of his Base Salary less the amount of any disability benefits
provided under the Corporation's long-term disability plans. In the event that
the Executive is totally or partially disabled and is not terminated for
Disability, the Corporation shall ensure that he continue to receive all
remuneration provided for under this Article 3.

         (c) The Executive shall have the use of a leased automobile or an
automobile allowance, provided the cost to the Corporation shall not exceed a
monthly amount of $1,000.

         (d) The Executive is not entitled to any other benefit or perquisite
other than as specifically set out in this Agreement or agreed to in writing by
the Corporation.

         The Executive understands and acknowledges that the perquisites
contemplated by this Section 3.3 shall be recorded as taxable benefits within
the meaning of the Income Tax Act (Canada) and will have comparable treatment
under the United States Internal Revenue Code.

3.4 VACATION. The Executive shall be entitled to five weeks' vacation with pay
annually. Such vacation shall be taken at a time or times acceptable to the
Corporation having regard to its operations. Accumulated vacation may not be
carried except with the written approval of the Corporation.

3.5      EXPENSES.

         (a) Consistent with its corporate policies as established from
time-to-time, the Corporation agrees to reimburse the Executive for all expenses
reasonably incurred in connection with the performance of his duties upon being
provided with proper vouchers or receipts.

         (b) The Corporation agrees to reimburse to the Executive for legal and
accounting expenses incurred in the negotiation and documentation of his
employment arrangements with the Corporation to a maximum amount of $15,000
(such legal fees to be paid within 90 days).

         (c) Although the Corporation's principal executive offices are located
in the Toronto, Ontario area, the Executive shall be under no obligation to
relocate his personal residence to the Toronto area. The Corporation shall
provide and maintain for the Executive suitable rental accommodations in the
Toronto area mutually acceptable

<PAGE>   4

to the Corporation and the Executive acting reasonably, and pay any costs
associated with the Executive's weekly commuting from Toronto to the Executive's
residences in Vero Beach and/or Philadelphia. The Executive's spouse shall be
entitled to make 12 round trips per year from her residence to Toronto at
Corporation's expense.

<PAGE>   5

3.6      SHARE OPTION.

         (a) Effective on the date of this Agreement but conditional on the
Executive complying with the provisions of subparagraph 3.6(b) below, the
Corporation will grant and the Executive will accept an irrevocable option (the
"Option") to purchase 1,300,000 common shares in the capital of the Corporation
(the "Optioned Shares") at a price to be fixed by the Corporation's board of
directors but equal to the closing share price on The Toronto Stock Exchange on
the date prior to the public announcement of this Agreement. The Option may be
exercised on a cumulative basis in respect of one-sixth (1/6) of the total
Optioned Shares commencing on the sixth monthly anniversary of the date of
grant, and thereafter in respect of one-thirtieth (1/30) the total unvested
Optioned Shares on each of the next 30 monthly anniversaries of this Agreement.
The Option shall expire in respect of Optioned Shares not theretofore acquired
thereunder or in respect of which rights shall not otherwise have terminated on
the seventh annual anniversary of the date of grant.

         (b) As a condition precedent of the exercise of the Option (or any
portion thereof), Subject to regulatory approval (which the Corporation
undertakes to seek), the Corporation agrees to issue and sell to the Executive
100,000 previously unissued common shares in its capital stock (the "Issued
Shares"), which will be issued as fully paid and non-assessable at an issue
price (the "Issue Price") equal to the closing market price on The Toronto Stock
Exchange on the date prior to the first public announcement of the Executive's
employment hereunder against cash payment by the Executive of an amount equal to
100,000 times the Issue Price. If such regulatory approval is not received the
Executive agrees to purchase on the open market 200,000 previously issued common
shares in the Corporation within 30 days of this Agreement (less the number of
such shares held by the Executive on the date of this Agreement) and to hold at
least that number of shares (as adjusted to reflect subdivisions, consolidations
or other share capital reorganizations) at the time of each exercise of the
Option, if the Executive is still an employee of the Corporation at the time of
such exercise, failing which the Option shall not be exercisable in respect of
the then unexercised portion thereof. If the Executive is required to purchase
common shares in the open market at a price in excess of the Issue Price, the
Corporation will reimburse the excess amount to the Executive (grossed up to
provide the Executive with an effective after-tax cost on the purchased shares
equal to the Issue Price). The Executive shall maintain no less than 200,000
common shares in the Corporation (adjusted as aforesaid) for the duration of his
employment with the Corporation and shall provide evidence of the shares held by
him as may be required by the Corporation from time-to-time.

         (c) The Executive covenants that he will comply with all applicable
securities laws and the Corporation's Insider Trading Policy and Insider
Reporting Procedures (copies of which have been provided to the Executive) in
respect of the Optioned Shares issued to the Executive and other shares of the
Corporation acquired by the Executive.

         (d) All of the Executive's rights in respect of the Option in the
Optioned Shares shall be governed by the terms and conditions set out in the
Restated 1986 Common Share Option Plan of the Corporation as amended through
September 4, 1997, as it may be amended from time to time, a copy of which has
been provided to the Executive, the provisions of which are incorporated into
this Agreement by reference.

<PAGE>   6

         (e) The Executive understands that the Issued Shares have not been and
will not be registered under the United States Securities Act of 1933 (the
"Securities Act") or any applicable state securities laws and that the
contemplated sale is being made in reliance on a private placement exemption
under the 1933 Act.

         (f) The Executive has had access to such information concerning the
Corporation as he has considered necessary in connection with its investment
decision to acquire the Issued Shares and has such knowledge and experience in
financial and business matters as to be capable of evaluating the merits and
risks of its investment in the Issued Shares and is able to bear the economic
risks of such investment.

         (g) The Executive is an Accredited Investor as confirmed in the
Accredited Investor Questionnaire attached hereto as Exhibit A and is acquiring
the Issued Shares for his own account, and not with a view to any resale,
distribution or other disposition of the Issued Shares in violation of the
United States securities laws or applicable state securities laws.

         (h) The Executive understands that if he decides to offer, sell or
other-wise transfer any of the Issued Shares, such Shares may be offered, sold
or otherwise transferred only, (i) to the Corporation, (ii) outside the United
States in accordance with Rule 904 of Regulation S under the 1933 Act, or (iii)
inside the United States in accordance with the exemption from registration
under the 1933 Act provided by Rule 144 thereunder, if available, or (iv)
pursuant to an effective registration statement, and that the certificate
representing the Issued Shares will bear a legend to the foregoing effect.

ARTICLE 4 - COVENANTS OF THE PARTIES

4.1      CONFIDENTIALITY.

         (a) The Executive acknowledges that in the course of carrying out,
performing and fulfilling his obligations to the Corporation hereunder, the
Executive will have access to and will be entrusted with information that would
reasonably be considered confidential to the Corporation or its Affiliates, the
disclosure of which to competitors of the Corporation or its Affiliates or to
the general public, will be highly detrimental to the best interests of the
Corporation or its Affiliates. Such information includes, without limitation,
trade secrets, know-how, marketing plans and techniques, cost figures, client
lists, software, and information relating to employees, suppliers, customers and
persons in contractual relationship with the Corporation. Except as may be
required in the course of carrying out his duties hereunder, the Executive
covenants and agrees that he will not disclose, for the duration of this
Agreement or at any time thereafter, any of such information to any person,
other than to the directors, officers, employees or agents of the Corporation
that have a need to know such information, nor shall the Executive use or
exploit, directly or indirectly, such information for any purpose other than for
the purposes of the Corporation (subject to his rights and obligations under
Section 3.6), nor will he disclose nor use for any purpose, other than for those
of the Corporation or its Affiliates or any other information which he may
acquire during his employment with respect to the business

<PAGE>   7

and affairs of the Corporation or its Affiliates. Notwithstanding all of the
foregoing, the Executive shall be entitled to disclose such information if
required pursuant to a subpoena or order issued by a court, arbitrator or
governmental body, agency or official, provided that the Executive shall first
have:

          (i)  notified the Corporation;

          (ii) consulted with the Corporation on the advisability of taking
               steps to resist such requirements;

         (iii) if the disclosure is required or deemed advisable, cooperate
               with the Corporation in an attempt to obtain an order or other
               assurance that such information will be accorded confidential
               treatment.

         (b) For the purposes of this Agreement, "Affiliate" shall mean, with
respect to any person or entity (herein the "first party"), any other person or
entity that directs or indirectly controls, or is controlled by, or is under
common control with, such first party. The term "control" as used herein
(including the terms "controlled by" and "under common control with") means the
possession, directly or indirectly, of the power to: (i) vote 50% or more of the
outstanding voting securities of such person or entity, or (ii) otherwise direct
or significantly influence the management or policies of such person or entity
by contract or otherwise.

4.2 INVENTIONS. The Executive acknowledges and agrees that all right, title and
interest in and to any information, trade secrets, advances, discoveries,
improvements, research materials and data bases made or conceived by the
Executive prior to or during his employment relating to the business or affairs
of the Corporation, shall belong to the Corporation. In connection with the
foregoing, the Executive agrees to execute any assignments and/or
acknowledgements as may be requested by the board of directors from time to
time.

4.3 CORPORATE OPPORTUNITIES. Any business opportunities related to the business
of the Corporation which become known to the Executive during his employment
hereunder must be fully disclosed and made available to the Corporation by the
Executive, and the Executive agrees not to take or attempt to take any action if
the result would be to divert from the Corporation any opportunity which is
within the scope of its business.

4.4      RESTRICTIVE COVENANTS

         (a) The Executive will not at any time, without the prior written
consent of the Corporation, during the Term of this Agreement or for a period of
24 months after the termination of this Agreement or the Executive's employment
(regardless of the reason for such termination), either individually or in
partnership, jointly or in conjunction with any other person or persons, firm,
association, syndicate, company or corporation, whether as agent, shareholder,
employee, consultant, or in any manner whatsoever, directly or indirectly:

<PAGE>   8

               (i)  anywhere in the Territory, engage in, carry on or otherwise
                    have any interest in, advise, lend money to, guarantee the
                    debts or obligations of, permit the Executive's name to be
                    used in connection with any business which is competitive to
                    the Business or which provides the same or substantially
                    similar services as the Business;

               (ii) for the purpose of competing with any business of the
                    Corporation, solicit, interfere with, accept any business
                    from or render any services to anyone who is a client or a
                    prospective client of the Corporation or any Affiliate at
                    the time Executive ceased to be employed by the Corporation
                    or who was a client during the 12 months immediately
                    preceding such time;

              (iii) solicit or offer employment to any person employed or
                    engaged by the Corporation or any Affiliate at the time the
                    Executive ceased to be employed by the Corporation or who
                    was an employee or during the 12 month period immediately
                    preceding such time.

     (b)  For the purposes of this Agreement:

               (i)  "Territory" shall mean Canada, the United States and the
                    United Kingdom;

               (ii) "Business" shall mean the business of manufacturing, selling
                    and distributing non-alcoholic beverages.

         (c) Nothing in this Agreement, shall prohibit or restrict the Executive
from holding or becoming beneficially interested in up to one (1%) percent of
any class of securities in any corporation provided that such class of
securities are listed on a recognized stock exchange in Canada or the United
States.

4.5      GENERAL PROVISIONS

         (a) The Executive acknowledges and agrees that in the event of a breach
of the covenants, provisions and restrictions in this Article 4, the
Corporation's remedy in the form of monetary damages will be inadequate and that
the Corporation shall be and is hereby authorized and entitled, in addition to
all other rights and remedies available to it, to apply for and obtain from a
court of competent jurisdiction interim and permanent injunctive relief and an
accounting of all profits and benefits arising out of such breach.

         (b) The parties acknowledge that the restrictions in this Article 4 are
reasonable in all of the circumstances and the Executive acknowledges that the
operation of restrictions contained in this Article 4 may seriously constrain
his freedom to seek other remunerative employment. If any of the restrictions
are determined to be unenforceable as going beyond what is reasonable in the
circumstances for the protection of the interests of the Corporation but would
be valid, for example, if the scope of their time periods or geographic areas
were limited, the parties consent to the

<PAGE>   9

court making such modifications as may be required and such restrictions shall
apply with such modifications as may be necessary to make them valid and
effective.

         (c) Each and every provision of these Sections 4.1, 4.2, 4.3, 4.4 and
4.5 shall survive the termination of this Agreement or the Executive's
employment hereunder (regardless of the reason or such termination).

ARTICLE 5 - TERMINATION OF EMPLOYMENT

5.1  TERMINATION BY THE CORPORATION FOR JUST CAUSE, DISABILITY OR DEATH OR
     NON-RENEWAL OF TERM

         (a) The Corporation may terminate this Agreement and the Executive's
employment hereunder without payment of any compensation either by way of
anticipated earnings or damages of any kind at any time for Just Cause,
Disability or death of the Executive, or at the expiry of the term subsequent to
the delivery of a Notice of Non-Renewal.

         (b)      "Just Cause" shall mean:

               (i)  misconduct or dishonesty in the discharge of his duties
                    hereunder;

               (ii) theft or misappropriation of the Corporation's property;

              (iii) alcoholism or addiction to a substance which materially
                    impairs the Executive's ability to perform his duties
                    hereunder;

               (iv) breach of fiduciary duties;

               (v)  incompetence or gross negligence in the performance of the
                    Executive's duties; or

               (vi) the Executive commits a material breach of this Agreement
                    and fails to remedy same, after notice from the Corporation,
                    within a period which is reasonable in the circumstances.

         (c) For the purposes of this Agreement, "Disability" shall have
occurred if the Executive has been unable due to illness, disease, or mental or
physical disability (in the opinion of a qualified medical practitioner who is
satisfactory to the Executive and the Corporation acting reasonably), to fulfil
his obligations hereunder either for any consecutive six (6) month period or for
any period of 9 months (whether or not consecutive) in any consecutive 12 month
period, or the Executive has been declared by a court of competent jurisdiction
to be mentally incompetent or incapable of managing his affairs.

         If the Executive and the Corporation cannot agree on a qualified
medical practitioner, each party shall select a medical practitioner, and the
two practitioners shall select a third who shall be the approved medical
practitioner for this purpose.

<PAGE>   10

5.2 TERMINATION BY THE EMPLOYER WITHOUT CAUSE. If the Executive's employment is
terminated by the Corporation for any reason other than for Just Cause,
Disability or death of the Executive, or expiry of the Term subsequent to the
delivery of a Notice of Non-Renewal, then the following provisions shall apply:

     (a) The Corporation shall pay forthwith to the Executive or as he may
direct, a lump sum amount equal to the greater of:

                    (i)  the Base Salary and the Bonus, calculated as the
                         average of the Bonuses paid or payable to the Executive
                         in respect of the most recent two completed fiscal
                         years (except, in the event that two fiscal years have
                         not been completed as of the date of termination, in
                         which case the most recent Bonus shall be utilized, and
                         that the Bonus payable in respect of the fiscal year
                         ending January 31, 1999 shall be pro-rated) for the
                         balance of the Term; or

                    (ii) 24 months' Base Salary and Bonus (based on the average
                         of the Bonuses paid or payable to the Executive in
                         respect of the most recent two completed fiscal years
                         except, in the event that two fiscal years have not
                         been completed as of the date of termination, in which
                         case the most recent Bonus shall be utilized, and the
                         Bonus payable in respect of the fiscal year ending
                         January 31, 1999 shall be pro-rated); and

                   (iii) apro rated Bonus for the year in which Executive's
                         termination occurs (calculated on the same basis as
                         indicated in Section 5.2(a)(i) above).

         (b) The Corporation shall, to the extent it may do so legally and in
compliance with the Corporation's benefit plans in existence from time to time,
continue all group insurance benefits at a level equivalent to those provided to
the Executive immediately prior to the termination for a period until the date
which is the latest of:

                    (i)  the expiry of the Term; or

                    (ii) 24 months following the date of termination.

provided that, (a) the benefits contemplated by this sub-paragraph shall
terminate on the date the Executive obtains alternate employment providing
comparable benefits; and (b) if the Corporation cannot continue any particular
group insurance benefit, the Corporation shall reimburse the Executive for any
expenses incurred by the Executive to replace such group insurance benefit.

5.3      TERMINATION BY THE EXECUTIVE FOR GOOD REASON.

         (a) The Executive may terminate this Agreement at any time for Good
Reason upon the occurrence, without the express written consent of the
Executive, of any of the following:

<PAGE>   11

                    (i)  a reduction in the Executive's then current Base Salary
                         or target award opportunity under the Corporation's
                         annual bonus plan or long-term performance incentive or
                         the termination or material reduction of any employee
                         benefit or perquisite enjoyed by him (other than as
                         part of an across-the-board reduction applicable to all
                         executive officers of the Corporation);

                    (ii) the failure to elect or reelect the Executive to any of
                         the positions described in Section 2.1 above (other
                         than the position of director of the Corporation) or
                         removal of him from any such position;

                   (iii) a material diminution in the Executive's duties or the
                         assignment to the Executive of duties which are
                         materially inconsistent with his duties or which
                         materially impair the Executive's ability to function
                         as the President and Chief Executive Officer of the
                         Corporation;

                    (iv) the failure to continue the Executive's participation
                         in any incentive compensation plan unless a plan
                         providing a substantially similar opportunity is
                         substituted;

                    (v)  the failure of the Corporation to obtain the assumption
                         in writing of its obligation to perform this Agreement
                         by any successor to all or substantially all of the
                         assets of the Corporation within 15 days after a
                         written request to that effect by the Executive
                         following a merger, consolidation, sale or similar
                         transaction, unless the Executive shall have received
                         the opinion of counsel to the Corporation that such
                         transaction does not have an adverse legal affect on
                         the rights of the Executive hereunder;

          which, in any of the foregoing events, has not been remedied or cured
          by the Corporation within a reasonable period after notice from the
          Executive.

         (b) In the event Executive terminates this Agreement for Good Reason,
he shall be entitled to the same payments and benefits as provided in Section
5.2 above.

5.4      TERMINATION UPON A CHANGE OF CONTROL.

         (a) If, following a Change in Control, the Executive's employment is
terminated without Just Cause or the Executive terminates his employment for
Good Reason, the Executive shall be entitled to the payments and benefits
provided in this Section 5.4. Also, immediately following a Change in Control,
all amounts, entitlements or benefits in which Executive is not vested shall
become fully vested. The Executive may terminate his employment at any time for
Good Reason upon the occurrence of a Change of Control by providing written
notice to the Corporation within six months of the occurrence of such Change of
Control and the effective date of such termination and the termination of the
Executive's employment shall be 30 days from the date of such written notice.

<PAGE>   12

         (b) For the purposes of this Agreement, a "Change of Control" shall
mean: (i) the occurrence, at any time during the Term of any person or group of
persons acting jointly or in concert acquiring more than 50% of the outstanding
voting shares in the Corporation, whether by way of takeover bid, merger,
amalgamation or otherwise; (ii) a sale by the Corporation of all or
substantially all of the Corporation's undertaking and assets; or (iii) the
voluntary liquidation, dissolution or winding-up of the Corporation, in
connection with which a distribution is made to the holders of the Corporation's
common shares.

         (c) In the event of termination of the Executive's employment pursuant
to this Section 5.3, then the following provisions shall apply:

                    (i)  The Corporation shall pay forthwith to the Executive or
                         as he may direct, a lump sum amount equal to 36 months
                         Basic Salary plus the average of the Bonuses paid or
                         payable to the Executive in respect of the most recent
                         two completed fiscal years (except in the event that
                         two fiscal years have not been completed as of the date
                         of termination, in which case the most recent Bonus
                         shall be utilized, and further, it is recognized that
                         the Bonus payable in respect of the fiscal year ending
                         January 31, 1999 shall be pro-rated); and

                    (ii) The Corporation shall continue, to the extent it may do
                         so legally and in compliance with the Corporation's
                         benefit plans in existence from time to time, all group
                         and insurance benefits at a level equivalent to those
                         provided to those provided to the Executive immediately
                         prior to the termination for a period of 36 months
                         following the date of termination, provided that, if
                         the Corporation cannot continue any particular group
                         insurance benefit, the Corporation shall reimburse the
                         Executive for any expenses incurred by the Executive to
                         replace such group insurance benefit.

                    (iii)In the event that the termination of the Executive's
                         employment is for one of the reasons set forth in this
                         Section 5.4 and the aggregate of all payments or
                         benefits made or provided to the Executive under this
                         Section 5.4 and under all other plans and programs of
                         the Corporation (the "Aggregate Payment") is determined
                         to constitute a Parachute Payment, as such term is
                         defined in Section 280G(b)(2) of the United States
                         Internal Revenue Code, the Corporation shall pay to the
                         Executive, prior to the time any excise tax imposed by
                         Section 4999 of the Internal Revenue Code ("Excise
                         Tax") is payable with respect to such Aggregate
                         Payment, an additional amount which, after the
                         imposition of all income and excise taxes thereon, is
                         equal to the Excise Tax on the Aggregate Payment. The
                         determination of whether the Aggregate Payment
                         constitutes a Parachute Payment and, if so, the amount
                         to be paid to the Executive and the time of payment
                         pursuant to this 5.4(c)(iii) shall be made by an
                         independent auditor (the "Auditor") jointly selected by
                         the Corporation and the Executive and paid by the
                         Corporation. The Auditor shall be a

<PAGE>   13

                              nationally recognized United States public
                              accounting firm which has not, during the two
                              years preceding the date of its selection, acted
                              in any way on behalf of the Corporation or any
                              Affiliate thereof. If the Executive and the
                              Corporation cannot agree on the firm to serve as
                              the Auditor, then the Executive and the
                              Corporation shall each select one accounting firm
                              and those two firms shall jointly select the
                              accounting firm to serve as the Auditor.

                    (iv)      In the event of any termination of employment
                              under this Article 5, the Executive shall be under
                              no obligation to seek other employment and there
                              shall be no offset against amounts due to the
                              Executive under this Agreement on account of any
                              remuneration attributable to any subsequent
                              employment that he may obtain except as
                              specifically provided in this Article 5.

                    (v)       Nature of Payments. Any amounts due under this
                              Article 5 are in the nature of severance payments
                              considered to be reasonable by the Corporation and
                              are not in the nature of a penalty.

5.5 VOLUNTARY RESIGNATION. In the event the Executive wishes to resign his
employment voluntarily, he shall provide six months' notice in writing to the
Corporation. The Corporation may waive such notice in whole or in part by paying
the Executive's Base Salary and continuing his group benefits and perquisites to
the effective date of resignation.

5.6 PAYMENT TO DATE OF TERMINATION. Regardless of the reasons for the
termination, the Corporation shall make payment to the Executive to the
effective date of termination for all Base Salary, any accrued but unpaid
vacation entitlements, any earned but unpaid Bonus and any other amounts earned,
accrued or owing to the Executive but not yet paid as well as other or
additional benefits in accordance with applicable plans or programs of the
Corporation.

5.7 RETURN OF PROPERTY. Upon any termination of this Agreement, the Executive
shall forthwith deliver or caused to be delivered to the Corporation all books,
documents, computer disks and diskettes and other electronic data, effects,
money, securities or other property belonging to the Corporation or for which
the Corporation is liable to others, which are in the possession, charge,
control or custody of the Executive.

5.8 RELEASE. The Executive acknowledges and agrees that the payments pursuant to
this Article shall be in full satisfaction of all terms of termination of his
employment, including termination pay and severance pay pursuant to the
Employment Standards Act (Ontario) as amended from time to time. Except as
otherwise provided in this Article, the Executive shall not be entitled to any
further termination payments, damages or compensation whatsoever. As a condition
precedent to any payment pursuant to this Article, the Executive agrees to
deliver to the Corporation prior to any such payment, a full and final release
from all actions or claims in connection therewith in favour of the Corporation,
its affiliates, subsidiaries, directors, officers, employees and agents, in a
form reasonably satisfactory to the Corporation.

<PAGE>   14

5.9 SET-OFF. Upon termination, howsoever caused, the Executive authorizes the
Corporation to deduct from any payment due to him pursuant to this Agreement,
any amounts owed to the Corporation howsoever caused, including by reason of
purchases, advances, loans, or in recompense for damages to or lawful property
and equipment. This provision shall be applied so as not to conflict with any
applicable legislation.

5.10 PROVINCIAL LEGISLATION. All payments made and notice given pursuant to this
Article 5 shall include notice of termination and severance pay as defined in
the Employment Standards Act (Ontario) as it may from time to time be amended,
the provisions of which are deemed to be incorporated into this Agreement and
shall prevail to the extent greater.

ARTICLE 6 - DIRECTORS AND OFFICERS

6.1 RESIGNATION. If the Executive is a director or officer at the relevant time,
the Executive agrees that after termination of his employment with the
Corporation he will tender his resignation from any position he may hold as an
officer or director of the Corporation or any of its affiliated or related
companies.

6.2 INSURANCE. The Corporation shall maintain such directors' and officers'
liability insurance for the benefit of the Executive in accordance with
corporate policies and as generally provided to the directors of the
Corporation.

6.3 INDEMNIFICATION. The Corporation agrees that, if the Executive is made a
party, or is threatened to be made a party, to any action, suit or proceeding,
whether civil, criminal, administrative or investigative (a "Proceeding"), by
reason of the fact that he is or was a director, officer or employee of the
Corporation or is or was serving at the request of the Corporation as a
director, officer, member, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise, including service with
respect to employee benefit plans, whether or not the basis of such Proceeding
is the Executive's alleged action in an official capacity while serving as a
director, officer, member, employee or agent, the Executive shall be indemnified
and held harmless by the Corporation to the fullest extent legally permitted or
authorized by the Corporation's certificate of incorporation or bylaws or
resolutions of the Corporation's Board of Directors or, if greater, by the laws
of the Province of Ontario, and the Federal Laws of Canada applicable to the
Corporation, against all cost, expense, liability, and loss (including, without
limitation, attorney's fees, judgments, fines, ERISA excise taxes or penalties
and amounts paid or to be paid in settlement) reasonably incurred or suffered by
the Executive in connection therewith, and such indemnification shall continue
as to the Executive even if he has ceased to be a director, member, employee or
agent of the Corporation or other entity and shall inure to the benefit of the
Executive's heirs, executors and administrators. The Corporation shall advance
to the Executive all reasonable costs and expenses incurred by him in connection
with a Proceeding within 20 days after receipt by the Corporation of a written
request for such advance. Such request shall include an undertaking by the
Executive to repay the amount of such advance if it shall ultimately be
determined that he is not entitled to be indemnified against such costs and
expenses.

ARTICLE 7 - ARBITRATION

<PAGE>   15

7.1 All matters in difference between the parties in relation to this Agreement,
shall be referred to the arbitration of a single arbitrator, if the parties
agree upon one, otherwise to three arbitrators, one to be appointed by the
Corporation and one to be appointed by the Executive and a third to be chosen by
the first two arbitrators named before they enter upon the business of
arbitration. The arbitration shall be conducted in accordance with the
Arbitrations Act (Ontario) as it may from time to time be amended. The award and
determination of the arbitrator or arbitrators or any of two of three
arbitrators shall be binding upon the parties and their respective heirs,
executors, administrators and assigns.

ARTICLE 8 - CONTRACT PROVISIONS

8.1 HEADINGS. The headings of the Articles and paragraphs herein are inserted
for convenience of reference only and shall not affect the meaning or
construction hereof.

8.2 INDEPENDENT ADVICE. The Corporation and the Executive acknowledge and agree
that they have each obtained independent legal advice in connection with this
Agreement and they further acknowledge and agree that they have read, understand
and agree with all of the terms hereof and that they are executing this
Agreement voluntarily and in good faith.

8.3 GENDER. Words denoting any gender include both genders.

8.4 GOVERNING LAW. This Agreement shall be construed and interpreted in
accordance with the laws of the Province of Ontario and the federal laws of
Canada applicable therein. Each of the parties hereby irrevocably attorns to the
jurisdiction of the courts of the Province of Ontario with respect to any
matters arising out of this Agreement.

8.5 ENTIRE AGREEMENT. This Agreement, together with the plans and documents
referred to herein, constitutes and expresses the whole agreement of the parties
hereto with reference to any of the matters or things herein provided for or
herein before discussed or mentioned with reference to such employment of the
Executive. All promises, representations, collateral agreements and
understandings not expressly incorporated in this Agreement are hereby
superseded by this Agreement.

8.6 SEVERABILITY. If any provision contained herein is determined to be void or
unenforceable in whole or in part, it shall not be deemed to affect or impair
the validity of any other provision herein and each such provision is deemed to
be separate and distinct.

8.7 NOTICE. Any notice required or permitted to be given under this Agreement
shall be in writing and shall be properly given if personally delivered,
delivered by facsimile transmission (with confirmation of receipt) or mailed by
prepaid registered mail addressed as follows:

          (a)       in the case of the Corporation:

<PAGE>   16

                    Cott Corporation
                    207 Queen's Quay West
                    Suite 800
                    Toronto, Ontario
                    M5J 1A7

                    Attention:  Chairman

          (b)       in the case of the Executive:

                    to the last address of the Executive
                    in the records of the Corporation
                    and its subsidiaries

or to such other address as the parties may from time to time specify by notice
given in accordance herewith. Any notice so given shall be conclusively deemed
to have been given or made on the day of delivery, if personally delivered, or
if delivered by facsimile transmission or mailed as aforesaid, upon the date
shown on the facsimile confirmation of receipt or on the postal return receipt
as the date upon which the envelope containing such notice was actually received
by the addressee.

8.8 SUCCESSORS. This Agreement shall enure to the benefit of and be binding upon
the parties hereto and their respective personal or legal representatives,
heirs, executors, administrators, successors and assigns.

8.9 TAXES. All payments under this Agreement shall be subject to withholding of
such amounts, if any, relating to tax or other payroll deductions as the
Corporation may reasonably determine and should withhold pursuant to any
applicable law or regulation.

8.10 CURRENCY. All dollar amounts set forth or referred to in this Agreement
refer to U.S. currency.

8.11 COUNTERPARTS. This Agreement may be executed in counterparts, each of which
shall be deemed to be an original but all of which together shall constitute one
and the same instrument.

<PAGE>   17

          IN WITNESS WHEREOF, the parties have executed this Agreement as of the
day and year first above written.

                                       COTT CORPORATION

                                       Per:     /s/ Fraser D. Latta

                                       I have authority to bind the Corporation

SIGNED, SEALED & DELIVERED  )
  in the presence of        )
                            )
Paul K. Henderson           )
                            )          /s/ Frank E. Weise
                                       FRANK E. WEISE III

<PAGE>   18

                                    EXHIBIT A

                        ACCREDITED INVESTOR QUESTIONNAIRE

The undersigned, as a purchaser of Common Shares (collectively the "Securities")
of Cott Corporation (the "Corporation"), has represented that the undersigned is
an "accredited investor" as defined in Rule 501 of Regulation D promulgated
under the Securities Act of 1933, as amended (the "1933 Act"). The undersigned
has indicated below the categories which it, he or she satisfies, or if he or
she is purchasing for the account of another accredited investor, which such
accredited investor satisfies.

The undersigned understands that the Corporation is relying on this information
in determining to sell securities to the undersigned in a manner exempt from the
registration requirements of the 1933 Act and applicable state securities laws.

(a)       ACCREDITED INVESTOR STATUS

          The undersigned represents and warrants that he is [CHECK EACH
APPLICABLE ITEM]:

          (a)       A bank, as defined in Section 3(a)(2) of the 1933 Act, or
                    savings and loan association or other institution as defined
                    in Section 3(a)(5)(A) of the 1933 Act, whether acting in its
                    individual or fiduciary capacity.

          (b)       A broker or dealer registered pursuant to Section 15 of the
                    United States Securities Exchange Act of 1934, as amended.

          (c)       An insurance company (as defined in Section 2(13) of the
                    1933 Act).

          (d)       An investment company registered under the United States
                    Investment Company Act of 1940 (the "1940 Act").

          (e)       A business development company (as defined in Section
                    2(a)(48) of the 1940 Act).

          (f)       A Small Business Investment Company licensed by the U.S.
                    Small Business Administration under Section 301(c) or (d) of
                    the United States Small Business Investment Act of 1958.

          (g)       A plan established and maintained by a state, its political
                    subdivisions, or any agency or instrumentality of a state or
                    its political subdivisions, for the benefit of its
                    employees, if such plan has total assets in excess of U.S.
                    $5,000,000.

          (h)       An employee benefit plan within the meaning of the United
                    States Employee Retirement Income Security Act of 1974
                    ("ERISA") (1) whose investment decision is made by a plan
                    fiduciary as defined in Section 3(21) of ERISA, which is
                    either a bank, savings and loan association,

<PAGE>   19

                    insurance company or registered investment advisor, or (2)
                    having total assets in excess of U.S. $5,000,000, or (3) if
                    a self-directed plan, with investment decisions made solely
                    by persons that are accredited investors.

          (i)       A private business development company (as defined in
                    Section 202(a)(22) of the United States Investment Advisers
                    Act of 1940).

          (j)       An organization described in Section 501(c)(3) of the
                    Internal Revenue Code, corporation, Massachusetts or similar
                    business trust, or partnership, not formed for the specific
                    purpose of acquiring the securities offered, having total
                    assets in excess of U.S. $5,000,000.

          (k)       A director or executive officer of the Company.

          (l)       A natural person with individual net worth, or joint net
                    worth with his spouse, at the time of purchase in excess of
                    U.S. $1,000,000.

          (m)       A natural person with an individual income in excess of U.S.
                    $200,000 in each of the last two years or joint income with
                    his spouse in excess of U.S. $300,000 in each of those
                    years, and who reasonably expects to reach the same income
                    level in the current year.

          (n)       A trust, with total assets in excess of U.S. $5,000,000, not
                    formed for the specific purpose of acquiring the securities
                    offered, whose purchase is directed by a sophisticated
                    person as described in section Rule 506 (b)(2)(ii) of the
                    1933 Act.

          (o)       An entity in which all of the equity owners are accredited
                    investors.

As used in this questionnaire, the term "net worth" means the excess of total
assets over total liabilities. In computing net worth for the purpose of
paragraph (1) above, the principal residence of the investor must be valued at
cost, including cost of improvements, or at recently appraised value by an
institutional lender making a secured loan, net of encumbrances. In determining
income, an investor should add to adjusted gross income any amount attributable
to tax exempt income received, losses claimed as a limited partner in any
limited partnership, deductions claimed for depletion, contributions to an IRA
or Keogh retirement plan, alimony payments, and any amount by which income from
long-term capital gains has been reduced in arriving at adjusted gross income.

IN WITNESS WHEREOF, the undersigned has executed this Questionnaire as of the
day of June ___, 1998.

                                             Signature

                                             /s/ Frank E. Weise, III

                                             Printed or Typed Name

<PAGE>   20

                               FRANK E. WEISE, III

                     Social Security or Taxpayer I.D. Number

                                COTT CORPORATION

                          STATEMENT OF RESPONSIBILITIES

                           - CHIEF EXECUTIVE OFFICER -

The Chief Executive Officer of Cott Corporation (the "Corporation") shall be
responsible for directing the Corporation with the objective of providing
maximum profit and return on invested capital, establishing short-term and
long-term objectives, plans, performance standards and policies subject to the
approval of the Board of Directors. To that end, the Chief Executive Officer
will be ultimately responsible for:

-         Preparing, at least annually, a statement of objectives, plans,
          performance standards and policies for the Corporation, which shall be
          reviewed by the Human Resources, Compensation and Corporate Governance
          Committee and shall be approved by the Board of Directors.

-         Ensuring that the Corporation's material operating plans, performance
          standards and policies are uniformly understood and properly
          interpreted and administered by subordinates.

-         Presenting proposed operating and capital expenditure budgets for
          review and approval by the Board of Directors.

-         Directing all investigations and negotiations pertaining to material
          acquisitions or dispositions, mergers and joint ventures.

-         Representing the Corporation as appropriate in its relationship with
          major customers, suppliers, competitors, commercial and investment
          bankers, investment analysts, the media, security holders, government
          agencies, professional associations, unions, employees and the public
          generally.

-         Analyzing the operating results of the Corporation and its principal
          divisions relative to established objectives and taking appropriate
          steps to correct unsatisfactory conditions.

-         Making recommendations to the Human Resources, Compensation and
          Corporate Governance Committee as regards Senior Officer succession
          planning and compensation.

-         Insuring the adequacy and soundness of the Corporation's financial
          structure and reviewing projections of working capital requirements.

<PAGE>   21

-         Delegating any or all of the above-noted responsibilities and
          maintaining ultimate supervisory responsibility to ensure that they
          are performed.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00006-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00006-of-00352.parquet"}]]